A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma-Reference-Cited by-同舟云学术

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma

Published:1988-04 Issue:4 Volume:24 Page:681-684
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Chisesi Teodoro,Capnist Giovanni,de Dominicis Ennio,Dini Enrico

Publisher

Elsevier BV

Subject

Oncology

Reference12 articles.

1. Comparison of biochemical and biological methods in the evaluation of new anthracycline drugs;di Marco;Antibiot Chemother,1978

2. Antileukemic activity of 4-demethoxydaunorubicin in mice;Casazza;Tumori,1980

3. Phase I–II clinical and pharmacology study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia;Daghestani;Cancer Res,1985

4. Therapeutic activity of 4-demethoxydaunorubicin (idarubicin) in adult acute leukemia;Lambertenghi-Deliliers;Tumori,1983

5. 4-Demethoxydaunorubicin (idarubicin) in refractory or relapsed acute leukemias: a pilot study;Carella;Cancer,1985

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity of 129 Single-Agent Drugs in 228 Phase I and II Clinical Trials in Multiple Myeloma;Clinical Lymphoma Myeloma and Leukemia;2014-08

2. Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma;Bone Marrow Transplantation;2004-08-02

3. Chemotherapy, steroids and interferon;Multiple Myeloma and Related Disorders;2004-04-30

4. Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients;The Hematology Journal;2004

5. Treatment of Multiple Myeloma;Biology and Management of Multiple Myeloma;2004